Thus, cusatuzumab treatment induced higher tumor cell death by promoting proliferation and cytotoxicity of CD8+ T cells in the PBMC co-culture system (Figs. 4e–i, Supplementary Figs. 4g,, h). This evidence concerns the gene CD8A and neoplasm.